Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2012; 18(43): 6277-6283
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6277
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6277
Virological recurrence(n = 20) | Virological non-recurrence(n = 28) | P value | |
Age, yr (mean ± SD) | 46.7 ± 12.1 | 38.8 ± 12.7 | 0.022 |
Sex (male/female) | 11/9 | 29/19 | 0.561 |
Pretreatment ALT level (IU/L) | 199 (40-374) | 189 (11-364) | 0.491 |
Pretreatment HBV DNA level (log10 copies/mL) | 7.7 (5.1-10) | 7 (5.0-9.1) | 0.125 |
Time to undetectable HBV (mo) | 6.7 (2.3-39.4) | 9.1 (1.3-25.0) | 0.490 |
Time to HBeAg seroconversion (mo) | 13.9 (0.8-39.4) | 12.7 (1.4-31.2) | 0.744 |
Consolidation treatment duration (mo) | 10.3 (6-23.9) | 11.7 (6-37.9) | 0.517 |
Total treatment duration (mo) | 25.6 (9.6-47.4) | 27.0 (9.4-43.3) | 0.358 |
Antiviral agent (entecavir/clevudine) | 15/5 | 16/12 | 0.236 |
- Citation: Song MJ, Song DS, Kim HY, Yoo SH, Bae SH, Choi JY, Yoon SK, Paik YH, Lee JS, Lee HW, Kim HJ. Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B. World J Gastroenterol 2012; 18(43): 6277-6283
- URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6277.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6277